Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437786-17-000055
Filing Date
2017-11-01
Accepted
2017-11-01 16:41:37
Documents
57
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q imdz930201710-q.htm 10-Q 958918
2 EXHIBIT 31.1 ex311imdz2017q3.htm EX-31.1 8015
3 EXHIBIT 31.2 ex312imdz2017q3.htm EX-31.2 8117
4 EXHIBIT 32.1 ex321imdz2017q3.htm EX-32.1 4874
5 EXHIBIT 32.2 ex322imdz2017q3.htm EX-32.2 5126
  Complete submission text file 0001437786-17-000055.txt   4467204

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT imdz-20170930.xml EX-101.INS 793250
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imdz-20170930.xsd EX-101.SCH 37534
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imdz-20170930_cal.xml EX-101.CAL 55438
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imdz-20170930_def.xml EX-101.DEF 171931
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imdz-20170930_lab.xml EX-101.LAB 514775
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imdz-20170930_pre.xml EX-101.PRE 290059
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

EIN.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36561 | Film No.: 171169484
SIC: 2834 Pharmaceutical Preparations